Company: VEEAW
Filing Date: 2025-08-12
Form Type: S-1/A
Source: 0001213900-25-074676
Chunk: 5

Company: VEEA INC.
Filing Date: 2025-08-12
Form: S-1/A
Chunk 5
---
5. except that the shares of common stock underlying the Investor Warrants will be offered on a continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “ Securities Act”). You should read this prospectus, together with additional information described under the heading “Where You Can Find More Information,” carefully before you invest in any of our securities. We are an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended (“ Securities Act”) and we have elected to comply with certain reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See the section entitled “ Risk Factors” beginning on page 10 of this prospectus for a discussion of risks that should be considered in connection with an investment in our securities. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

|                                      |     | Per Share and accompanying Common 
 Warrant                           |   |     | Per Pre-Funded Warrant and accompanying 
 Common Warrant                          |     | Total |   |
|:-------------------------------------|:----|:----------------------------------|:--|:----|:----------------------------------------|:----|:------|:--|
| Public offering price                |     | $                                 | – |     | $                                       |     | $     | – |
| Placement Agent fees(1)              |     | $                                 |   |     | $                                       |     | $     |   |
| Proceeds, before expenses, to us (2) |     | $                                 |   |     | $                                       |     | $     |   |

| (1) | We have agreed to pay the Placement Agent a cash fee equal to the sum of (i) 7.0% of the aggregate gross proceeds raised in the offering by the investors introduced by the Placement Agent plus 
 (ii) 3.5% of the aggregate gross proceeds raised in the offering by the investors introduced by the Company, provided, however, that                                                             
 the Placement Agent shall receive no cash fee for any payment made by NLabs in the form of the 2025 Related Party Notes (as defined                                                              
 below) for the shares of common stock and common warrants sold in this offering in satisfaction of such indebtedness. We have also                                                               
 agreed to reimburse the Placement Agent for certain of